Ignite Creation Date:
2025-12-25 @ 4:09 AM
Ignite Modification Date:
2026-02-25 @ 9:36 PM
Study NCT ID:
NCT02079220
Status:
WITHDRAWN
Last Update Posted:
2017-07-31
First Post:
2014-03-03
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase II Study of Ziv-aflibercept in Combination With Capecitabine/Oxaliplatin (XELOX) Chemotherapy in the Front-Line Treatment of Patients With Metastatic Colorectal Cancer
Sponsor:
James J Lee
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
13-145
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |